Problem 8 - Campbell Biology Concepts & Connections

Question

Within a few weeks of treatment with the drug \(3 \mathrm{TC}\), a patient's HIV population consists entirely of 3TC-resistant viruses. How can this result best be explained? a. HIV can change its surface proteins and resist vaccines. b. The patient must have become reinfected with a resistant virus. c. A few drug-resistant viruses were present at the start of treatment, and natural selection increased their frequency. d. HIV began making drug-resistant versions of its enzymes in response to the drug.

Step-by-Step Solution

Answer

Option c: A few drug-resistant viruses were present at the start of treatment, and natural selection increased their frequency.

Step 1: Understanding the Scenario

Within a few weeks of treatment with the drug 3TC, a patient's HIV population consists entirely of 3TC-resistant viruses. The task is to determine how this result can best be explained.

Step 2: Analyzing Each Option

Go through each of the given options and evaluate their validity based on the scenario.

Step 3: Evaluate Option a

Option a suggests that HIV can change its surface proteins and resist vaccines. This does explain how HIV resists vaccines, but it doesn’t directly explain the rapid emergence of 3TC-resistant viruses.

Step 4: Evaluate Option b

Option b claims the patient must have been reinfected with a resistant virus. However, there’s no evidence to suggest reinfection and the scenario specifically points to the development of resistance during treatment, not prior to it.

Step 5: Evaluate Option c

Option c suggests that a few drug-resistant viruses were present at the start of treatment, and natural selection increased their frequency. This is a plausible explanation as some viruses with resistance could survive treatment and multiply.

Step 6: Evaluate Option d

Option d proposes that HIV started making drug-resistant versions of its enzymes in response to the drug. However, HIV does not generate resistant versions on-demand but rather drug-resistant variants would have pre-existed and were selected for during treatment.

Step 7: Compare and Conclude

After comparing all options, Option c provides the most reasonable explanation. The presence of a few resistant viruses at the start and their increased frequency due to natural selection explains how the entire HIV population becomes resistant.

Key Concepts

Natural Selection

Natural selection is a fundamental concept in evolutionary biology. It explains how species evolve over time due to variations in their traits.
In the context of HIV, natural selection is responsible for the rapid emergence of drug-resistant viruses during antiviral treatment.
When a patient begins treatment with a drug like 3TC, there might already be a tiny number of viruses that are naturally resistant to the drug. While the drug kills off most of the non-resistant viruses, these resistant ones survive.
Due to their survival advantage, they multiply and soon dominate the viral population. This process of more resistant viruses surviving and reproducing more effectively compared to non-resistant ones, leads to the entire population becoming resistant.
The key points of natural selection are:

• Variation: There are differences in traits (e.g., resistance to 3TC) among individuals in a population.
• Inheritance: Resistant traits can be passed on to the next generation.
• High rate of reproduction: Organisms often produce more offspring than the environment can support.
• Survival of the fittest: Individuals with advantageous traits (e.g., drug resistance) are more likely to survive and reproduce.

Understanding natural selection helps explain why drug resistance in HIV can develop so quickly, making it challenging to treat effectively.

Mutation

Mutations are changes in the genetic code of an organism. In the case of HIV, mutations frequently occur during replication.
HIV is a virus that rapidly reproduces in the host's body, and its replication process is error-prone. This leads to many genetic variations, or mutations.
Some of these mutations may confer resistance to antiviral drugs like 3TC. Though most mutations might be neutral or even harmful to the virus, occasionally, a mutation will give the virus a survival advantage.
For instance, a mutation could alter a viral enzyme in a way that allows the virus to continue replicating even in the presence of the drug. When treatment begins, the drug-resistant mutants have a better chance of surviving and reproducing than the non-resistant ones.
Over time, these resistant strains become more common within the viral population, leading to drug resistance.
Key aspects of mutation include:

• Random nature: Mutations occur randomly and are not a response to the environment.
• Source of variation: Mutations are the primary source of genetic variation in populations.
• Potential for resistance: Some mutations can provide a survival advantage, such as drug resistance.

This underlines the significance of genetic mutations in the development of drug-resistant HIV strains.

Antiviral Treatment

Antiviral treatments are medications used to treat viral infections by inhibiting the development of the virus.
In the case of HIV, antiviral drugs like 3TC are designed to target specific stages of the viral replication cycle.
The goal is to reduce the viral load in the patient's body, improve immune function, and delay the progression to AIDS. However, because of the rapid mutation rate of HIV, the virus can quickly develop resistance to these drugs.
During treatment, selective pressure is placed on the viral population. While it suppresses susceptible viruses, any pre-existing resistant viruses can continue to replicate.
Effective antiviral treatment often involves combination therapy, using multiple drugs simultaneously to reduce the chance of resistance developing.
Key components of antiviral treatments include:

• Targeting specific viral functions: Drugs are designed to inhibit key processes like enzyme functions.
• Reducing viral load: Lowering the amount of virus in the body helps prevent disease progression.
• Combination therapy: Using more than one drug to decrease the likelihood of resistance.

The complexity of treating HIV underscores the importance of understanding viral replication, mutation, and how treatments can drive the evolution of drug resistance.